Like Us
You are here: Library Additional Reading Berkley (UC) Press Release ALA & ALC 18-02-2002

Berkley (UC) Press Release ALA & ALC 18-02-2002

Alpha-Lipoic Acid & Acetyl-LCarnitine
New Evidence for Rejuvenation Potential
University of California - Berkeley Press Release, Feb 18th 2002
Two dietary supplements straight off the health food store shelf put the spark back into aging rats, and might do the same for aging baby boomers, according to a study at the University of California, Berkeley, and Children’s Hospital Oakland Research Institute. A team of researchers led by Bruce N. Ames, professor of molecular and cell biology at UC Berkeley, fed older rats two chemicals normally found in the body’s cells and available as dietary supplements: Acetyl-L-carnitine and an antioxidant, Alpha-Lipoic Acid. In three articles in the February 19 issue of Proceedings of the National Academy of Sciences, Ames and his colleagues report the surprising results. Not only did the older rats do better on memory tests, they had more pep, and the energy-producing organelles in their cells worked better.
"With the two supplements together, these old rats got up and did the Macarena,” said Ames, also a researcher at Children’s Hospital Oakland Research Institute (CHORI). "The brain looks better, they are full of energy - everything we looked at looks more like a young animal…."The animals seem to have much more vigour and are much more active than animals not on this diet, signalling massive improvement to these animals’ health and well-being,” said former UC Berkeley post-doctoral fellow Tory M. Hagen, now an assistant professor at the Linus Pauling Institute at Oregon State University, Corvallis. "And we also see a reversal in loss of memory. That is a dual-track improvement that is significant and unique. This is really starting to explode and move out of the realm of basic research into people.”
Based on the group’s earlier studies, the University of California patented use of the combination of the two supplements to rejuvenate cells. Ames, through the Bruce and Giovanna Ames Foundation, and Hagen founded a company in 1999 called Juvenon to license the patent from the university. Juvenon currently is engaged in human clinical trials of the combination. One of the three PNAS articles probes the reasons behind this rejuvenation, concluding that the two chemicals "tune up” the energy-producing organelles that power all cells, the mitochondria. Both chemicals are normally used in mitochondria.  Ames calls mitochondria the weak link in aging.
” Evidence has been piling up, he said, that deterioration of mitochondria is an important cause of aging.”
A significant cause of this deterioration, he believes, is the accumulation of destructive free radicals — by products of normal metabolism — that disable enzymes and other chemicals. The combination therapy targets mitochondria to get rid of destructive radicals and to boost the activity of a damaged enzyme, carnitine acetyltransferase, which plays a key role in burning fuel in mitochondria. The researchers hoped that the anti-oxidant alpha-lipoic acid would do the former, and that flooding the cell with acetyl-L-carnitine, one of two proteins that the enzyme acts on, would achieve the latter.
Experiments showed that this regimen worked. Associate researcher Jiankang Liu of CHORI, UC Berkeley postdoctoral fellow David W. Killilea and Ames demonstrated that the enzyme carnitine acetyltransferase is less active in old rats than in young rats, and that it binds less tightly to acetyl-L-carnitine in older rats. Supplementation with acetyl-L-carnitine or a combination of acetyl-L-carnitine and alpha-lipoic acid restored the enzyme’s activity nearly to that found in young rats and substantially restored binding to acetyl-L-carnitine.
"The acetyl-L-carnitine is protecting the protein and the higher levels are enabling the protein to work, while alpha-lipoic acid knocks down oxygen radicals,” Ames said. "Each chemical solves a different problem — the two together are better than either one alone.”
Ames and Hagen have long had an interest in mitochondria as they relate to aging, and they were intrigued by a 1999 Italian study that showed acetyl-L-carnitine, when fed to old rats, improved mitochondrial activity. The two thought this might be a way to reverse the effects of aging on mitochondria, and in various trials found it to work to some degree. Free radicals were still damaging the cell, however, so they decided to pair it with one of the few antioxidants that gets into mitochondria, alpha-lipoic acid. Lipoic acid is produced by mitochondria and boosts levels of other antioxidants. In the second of the PNAS studies, Hagen, Ames and colleagues compared 2- to 4-month-old rats to 24- to 28-month-old rats, all fed acetyl-L-carnitine in their water and alpha-lipoic acid in their chow. After as little as a month on the supplements, the old and lethargic rats became more peppy, Ames said.
"We significantly reversed the decline in overall activity typical of aged rats to what you see in a middle-aged to young adult rat 7 to 10 months of age,” Hagen said. "This is equivalent to making a 75- to 80-year-old person act middle-aged. We’ve only shown short-term effects, but the results give us the rationale for looking at these things long term.”
They found also that the combination of lipoic acid and acetyl-carnitine improved mitochondrial activity and thus cellular metabolism, and increased levels of various chemicals known to decline with age, including ascorbic acid, an antioxidant.
In a third study, Liu, Hagen, Ames and colleagues fed old rats a similar diet of the two supplements and looked at memory function as measured by the Morris water maze test and a peak procedure for assessing temporal or time-based memory developed by Seth Roberts, professor of psychology at UC Berkeley.
They found that supplementation improved both spatial and temporal memory, and reduced the amount of oxidative damage to RNA in the brain’s hippocampus, an area important in memory. In electron microscope pictures of cells from the hippocampus, mitochondria showed less structural decay in old rats that had a supplemented diet.
"We did two different tests for cognitive activity in rats, and in both it made a big difference to feed them this mixture,” Ames said. "Memory degenerates with age, and this makes them better.”
The analysis of nucleic acid damage in the brain was performed with post-doctoral researcher Elizabeth Head and Carl W. Cotman, professor of neurobiology and behaviour, at the Institute for Brain Aging and Dementia at UC Irvine. UC Berkeley psychology graduate student Afshin M. Gharib worked with Liu to conduct the peak performance tests. "In aging, you’re oxidizing the proteins in mitochondria and they lose activity,” Ames explained. "If some of that lost activity is due to binding for substrate or coenzyme — like binding of acetyl-L-carnitine by carnitine acetyltransferase — and you can raise the level of those, then you can reverse some of the loss”.
"We showed, in fact, that that is what’s happening with acetyl-L-carnitine. Aldehydes from lipid oxidation are glomming onto that protein, and that is what appears to cause the reduction in binding activity. But if you raise the level of acetyl-L-carnitine, now it works.” Hagen added,  "With aging, we see so many different things that are occurring to mitochondria that then lead to consequences in the cell. If you tune up mitochondria you may have a means of at least delaying the onset of a number of age-related problems that we encounter, or we can in some ways, hopefully, reverse what has already taken place.”
The work was supported by grants from the Ellison Foundation, the National Institute on Aging of the National Institutes of Health, the Wheeler Fund of the Dean of Biology at UC Berkeley, the Bruce and Giovanna Ames Foundation and the National Institute of Environmental Health Sciences Center at UC Berkeley.
Alpha Lipoic Acid and Acetyl-L-Carnitine References and Key Studies
Jameel NM, Shekhar MA, Vishwanath BS. Alpha-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity Life Sci 2006 Dec 14;80(2):146-53. Epub 2006 Sep 1
Brevetti G, Chiariello M, Ferulano G, Policicchio A, Nevola E, Rossini A, Attisano T, Ambrosio G, Siliprandi N and Angelini C (1988). Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double blind, cross-over study. Circulation 77: 767-773
Lee WJ, Song KH, Koh EH, Won JC, Kim HS, Park HS, Kim MS, Kim SW, Lee KU, Park JY Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle Biochem Biophys Res Commun 2005 Jul 8;332(3):885-91
Tankova, T; Cherninkova, S.; Koev, D Treatment for diabetic mononeuropathy with lipoic acid International Journal of Clinical Practice, Volume 59, Number 6, June 2005, pp. 645-650(6)
Athanassakis I, Zarifi I, Evangeliou A and Vassiliadis S (2002). L-Carnitine accelerates the in vitro regeneration of neuronal network from adult murine brain cells. Brain Research 932: 70-78
Jacob S; Ruus P.; Hermann R.; Tritschler H.J.; Maerker E.; Renn W.; Augustin H.J.; Dietze G.J.; Rett K Oral administration of rac- -lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial - the Carvedilol Metoprolol Study Free Radical Biology and Medicine, Volume 27, Number 3, August 1999, pp. 309-314(6)
Jacob S, Henriksen EJ, Tritschler HJ, Augustin HJ and Dietz GJ (1996). Improvement of insulin-stimulated glucose disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Endocrinology and Diabetes 104: 284-288
Badiali De Giorgi L, Bonvicini F, Bianchi D, Bossoni G and Laschi R (1987). Ultrastructural aspects of ageing rat hippocampus and effects of L-acetyl-carnitine treatment. Drugs Under Experimental and Clinical Research 13: 185-189
Brass EP, Scarrow AM, Ruff LJ, Masterson KA and Lunteren EV (1993). Carnitine delays rat skeletal muscle fatigue in vitro. American Journal of Physiology 263: 1595-1600
Curti D, Dagani F, Galmozzi MR and Marzatico F (1989). Effect of aging and acetyl-L-carnitine on energetic and cholinergic metabolism in rat brain regions. Mechanisms of Ageing and Development 47: 39-45
Hagen TM, Ingersoll RT, Lykkesfeldt J, et al. (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J. 1999; 13:411-418
Low P., Dotson R. Symptomatic Treatment of Painful Neuropathy. Jama. 1998 Dec 280:1983-1864
Lykkesfeldt J, Hagen TM, Vinarsky V, Ames BN. Age-associated decline in ascorbic and concentration, recycling and biosynthesis in rat hepatocytes-reversal with (R)-alpha-lipoic acid supplementation. FASEB J. 1998; 12:1183-1189
Marangon K, Devaraj S, Tirosh O, et al. Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress. Free Rad Biol Med. 1999; 27:1114-1121
Natrej CV, Gandhi VM, Melon KKG. Lipoic acid and diabetes: effect of dihydrolipoic acid administration in diabetic rats and rabbits. J Biosci 1984; 6:37-46
Ferrari R, DiMauro S and Sherwood G (1992). L-Carnitine and its Role in Medicine: From Function to Therapy. London: Academic Press
Imperato A, Scrocco MG, Ghirardi O, Ramacci MT and Angelucci L (1991). In vivo probing of the brain cholinergic system in the aged rat: effects of long term-term treatment with Acetyl-L-Carnitine. Annals of the New York Academy of Sciences 621: 90-97
Nickander KK, McPhee BR, Low PA, Tritschler H. Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Rad Biol Med. 1996; 21:631-639
Lui J, Killilea DW and Ames BN (2002a). Age-associated mitochondrial oxidative decay: Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-a-lipoic acid. Proceedings of the National Academy of Sciences 99: 1876-1881
Ohmori H, Yamauchi T, Yamamoto I. Augmentation of the antibody response by lipoic acid in mice II. Restoration of the antibody response in immunosuppressed mice. Japan J Pharmacol 1986; 42:275-280
Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Rad Biol Med. 1997; 22:359-378
Passer M, Cucinotta D, Bonati PA, Iannuccelli M, Parnetti L and Senin U (1990). Acetyl-L-carnitine in the treatment of mildly demented patients. International Journal of Clinical Pharmacology Research 10: 75-79
Packer L, Witt EH, Tritschler, HJ. Alpha-lipoic as a biological antioxidant. Free Rad Biol Med. 1995; 19:227-250
Reed LJ. The chemistry and function of lipoic acids. Adv Enzymol. 1957; 18:319-347.
Sachse G, Willms B. Efficacy of throctic acid in the therapy of peripheral diabetic neuropathy. Horm Metab Res Suppl. 1980; 9:105-107
Tirosh O, Sen CK, Roy S, et al. Neuroprotective effects of alpha-lipoic acid and its positively charged amide analogue. Free Rad Biol Med. 1999; 26:1418-1426
Wagh SS, Natraj CV, Menon KKG. Mode of action of lipoic acid in diabetes. J Biosci. 1987; 11:59-74
Wachter S, Vogt M, Kries R, Boesch C, Bigler P, Hoppeler H and Krahenbuhl S (2002). Long-term administration of L-carnitine to humans: effect on skeletal muscle carnitine content and physical performance. Clin Chim Acta 318: 51-61
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid. A three-week multicentre randomized controlled trial (ALADIN study). Diabetologia. 1995; 38:1425-1433
Zimmer G, Beikler TK, Schneider M, et al. Dose/response curves of lipoic acid R- and S- forms in the working rat heart during reoxygenation: superiority of the R-entantiomer in the enhancement of aortic flow. J Mol Cell Cardiol. 1995; 27:1895-1903

Thousands of pages... at your fingertips

Worldwide Delivery Included in the Price
Mobile / Tablet users may prefer our mobile optimised website | Privacy and Cookies Policy

Disclaimer: Regenerative Nutrition advocates a holistic approach to natural health and wellbeing. The body's ability and power to heal depends upon the totality of diet, nutrition, lifestyle and environmental factors. The information provided in our article is for information purposes only, it in no way constitutes a medical consultation, or medical advice, nor is it intended to be taken as a solicitation to purchase our products.

Always consult a health care practitioner when combating disease states.

No claim for the cure of any disease is intended, or implied nor do we claim that our products will treat, cure or prevent any disease.